Cargando…
Blood glucose and insulin concentrations after alpha‐2‐agonists administration in horses with and without insulin dysregulation
BACKGROUND: In metabolically stable horses, alpha‐2‐agonists suppress insulin secretion with transient hyperglycemia and rebound hyperinsulinemia. In horses with insulin dysregulation (ID), the effect of alpha‐2‐agonists has not been investigated; however, both the alpha‐2‐agonist‐induced suppressio...
Autores principales: | Kritchevsky, Janice E., Muir, Genevieve S., Leschke, Dakota H. Z., Hodgson, Jack K., Hess, Emily K., Bertin, Francois‐Rene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096659/ https://www.ncbi.nlm.nih.gov/pubmed/32100334 http://dx.doi.org/10.1111/jvim.15747 |
Ejemplares similares
-
Immunoreactive insulin stability in horses at risk of insulin dysregulation
por: Leschke, Dakota H., et al.
Publicado: (2019) -
Insulin dysregulation in horses with systemic inflammatory response syndrome
por: Bertin, François‐René, et al.
Publicado: (2018) -
Blood Glucose and Insulin Concentrations after Octreotide Administration in Horses With Insulin Dysregulation
por: Frank, N., et al.
Publicado: (2017) -
Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses
por: Horn, Remona, et al.
Publicado: (2019) -
The Effect of Fasting Duration on Baseline Blood Glucose Concentration, Blood Insulin Concentration, Glucose/Insulin Ratio, Oral Sugar Test, and Insulin Response Test Results in Horses
por: Bertin, F.R., et al.
Publicado: (2016)